Log in

NASDAQ:AKCAAkcea Therapeutics Earnings Date, Estimates & History

$10.88
-0.31 (-2.77 %)
(As of 08/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$9.81
Now: $10.88▼
$10.98
50-Day Range
$10.84
MA: $13.21▼
$15.46
52-Week Range
$8.00
Now: $10.88▼
$23.98
Volume367,772 shs
Average Volume218,459 shs
Market Capitalization$1.10 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.06

Earnings

Akcea Therapeutics (NASDAQ:AKCA) Earnings Information

Akcea Therapeutics last issued its earnings results on August 4th, 2020. The reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by $0.14. The firm had revenue of $22.38 million for the quarter, compared to analyst estimates of $30.93 million. Its revenue was down 15.9% on a year-over-year basis. Akcea Therapeutics has generated $0.48 earnings per share over the last year. Akcea Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 3rd, 2020 based off prior year's report dates.

Akcea Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Akcea Therapeutics (NASDAQ:AKCA) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.37 EPS
Next Year EPS Consensus Estimate: $-2.08 EPS

Akcea Therapeutics (NASDAQ AKCA) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/3/2020
(Estimated)		       
8/4/20206/30/2020($0.35)($0.49)$30.93 million$22.38 millionTranscript
5/5/20203/31/2020($0.45)($0.42)($0.42)$34.85 million$16.07 millionTranscript
2/25/2020Q4 2019$2.10$0.86$0.86$225.94 million$277.48 millionTranscript
11/5/2019Q3 2019($0.55)($0.34)($0.34)$22.54 million$20.62 millionTranscript
8/6/2019Q2 2019($0.38)($0.4022)($0.40)$25.78 million$26.62 millionListen
5/8/2019Q1$1.24$0.34$0.34$171.40 million$163.82 millionListen
2/26/2019Q4 2018($0.70)($0.79)($0.79)$17.76 million$10.20 millionListen
11/5/2018Q3 2018($0.97)($0.73)($0.73)$20.52 million$19.24 millionN/A
8/6/2018Q2 2018($0.75)($0.75)$14.24 million$18.30 millionN/A
5/3/2018Q1 2018($0.37)($0.44)($0.44)$12.12 million$17.11 millionN/A
2/26/2018Q4 2017($0.23)($0.26)($0.17)$15.48 million$18.04 millionN/A
11/6/2017Q3 2017($0.21)($0.18)($0.09)$15.48 million$13.45 millionN/A
8/8/2017Q2 2017($0.27)($0.13)$14.13 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/6/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.